BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32564280)

  • 1. Metabolic risk factors in children with kidney stone disease: an update.
    Spivacow FR; Del Valle EE; Boailchuk JA; Sandoval Díaz G; Rodríguez Ugarte V; Arreaga Álvarez Z
    Pediatr Nephrol; 2020 Nov; 35(11):2107-2112. PubMed ID: 32564280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic risk factors in children with kidney stone disease.
    Spivacow FR; Negri AL; del Valle EE; Calviño I; Fradinger E; Zanchetta JR
    Pediatr Nephrol; 2008 Jul; 23(7):1129-33. PubMed ID: 18324422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stone growth patterns and risk for surgery among children presenting with hypercalciuria, hypocitraturia and cystinuria as underlying metabolic causes of urolithiasis.
    Zu'bi F; Sidler M; Harvey E; Lopes RI; Hojjat A; Naoum N; Pokarowski M; Lorenzo AJ; Farhat WA; Papanikolaou F; Dos Santos J
    J Pediatr Urol; 2017 Aug; 13(4):357.e1-357.e7. PubMed ID: 28865885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and metabolic risk factor evaluation in young adults with kidney stones.
    Spivacow FR; Negri AL; del Valle EE; Calviño I; Zanchetta JR
    Int Urol Nephrol; 2010 Jun; 42(2):471-5. PubMed ID: 19653114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic disturbances in Chinese children with urolithiasis: a single center report.
    Yang D; Tiselius HG; Lan C; Chen D; Chen K; Ou L; Liu Y; Xu S; Zeng G; Lei M; Wu W
    Urolithiasis; 2017 Jun; 45(3):285-290. PubMed ID: 27510800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and spot urine risk factors for renal stones in children taking topiramate.
    Corbin Bush N; Twombley K; Ahn J; Oliveira C; Arnold S; Maalouf NM; Sakhaee K
    J Pediatr Urol; 2013 Dec; 9(6 Pt A):884-9. PubMed ID: 23375465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked increase in urinary excretion of apolipoproteins in children with nephrolithiasis associated with hypercalciuria.
    Kovacevic L; Lu H; Caruso JA; Govil-Dalela T; Thomas R; Lakshmanan Y
    Pediatr Nephrol; 2017 Jun; 32(6):1029-1033. PubMed ID: 28188435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From hypercalciuria to hypocitraturia--a shifting trend in pediatric urolithiasis?
    Kovacevic L; Wolfe-Christensen C; Edwards L; Sadaps M; Lakshmanan Y
    J Urol; 2012 Oct; 188(4 Suppl):1623-7. PubMed ID: 22910255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for nephrolithiasis in children.
    Acar B; Inci Arikan F; Emeksiz S; Dallar Y
    World J Urol; 2008 Dec; 26(6):627-30. PubMed ID: 18810456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Unilateral renal agenesis. New arguments about the genetic relationship between kidney malformations and urolithiasis].
    Garcia Nieto V; Huertes Díaz B; Escribano Subias J; Alarcón Alacio MT; Gonzalez Rodríguez JD; Cabrera Sevilla JE; Peralta Aros C; Luis Yanes MI
    An Pediatr (Barc); 2016 Nov; 85(5):240-246. PubMed ID: 26669685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic risk factors in children with asymptomatic hematuria.
    Spivacow FR; Del Valle EE; Rey PG
    Pediatr Nephrol; 2016 Jul; 31(7):1101-6. PubMed ID: 26913725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary citrate excretion in children with calcium urolithiasis].
    Sikora P; Bieniaś B; Majewski M; Borzecka H; Wawrzyszuk M; Zajaczkowska M
    Przegl Lek; 2006; 63 Suppl 3():134-6. PubMed ID: 16898511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ability of a limited metabolic assessment to identify pediatric stone formers with metabolic abnormalities.
    Chan KH; Moser EA; Whittam BM; Misseri R; Cain MP; Krambeck A
    J Pediatr Urol; 2018 Aug; 14(4):331.e1-331.e6. PubMed ID: 30177386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of hypocitraturia in kidney stone patients.
    Matsushita K; Tanikawa K; Masuda A; Matsuzaki S
    Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1253-7. PubMed ID: 8139138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for recurrence in pediatric urinary stone disease.
    Demirtas F; Çakar N; Özçakar ZB; Akıncı A; Burgu B; Yalçınkaya F
    Pediatr Nephrol; 2024 Jul; 39(7):2105-2113. PubMed ID: 38273078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical risk factors for stone formation in healthy school children.
    Akhavan-Sepahi M; Sharifian M; Mohkam M; Vafadar M; Hejazi S
    Acta Med Iran; 2012; 50(12):814-8. PubMed ID: 23456523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
    Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
    Huynh LM; Dianatnejad S; Tofani S; Carrillo Ceja R; Liang K; Tapiero S; Jiang P; Youssef RF
    Scand J Urol; 2020 Dec; 54(6):456-462. PubMed ID: 33185135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical factors of the urine of children with hypercalciuria.
    Ubetagoyena-Arrieta M; Martínez Sáenz de Jubera J; Corera-Casty MN; González Pérez-Yarza E; García-Albizua I
    Arch Esp Urol; 2017 Apr; 70(3):342-348. PubMed ID: 28422036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.